Knopp Biosciences Broadens Collaboration With National Institutes of Health (NIH) To Investigate Eosinophil-Lowering Effects Of Dexpramipexole
PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC today announced a second collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to investigate the eosinophil-lowering effects of the investigational drug dexpramipexole.
Help employers find you! Check out all the jobs and post your resume.